Literature DB >> 24139178

The effect of bacterial dose and foal age at challenge on Rhodococcus equi infection.

M Sanz1, A Loynachan, L Sun, A Oliveira, P Breheny, D W Horohov.   

Abstract

While Rhodococcus equi remains the most common cause of subacute or chronic granulomatous bronchopneumonia in foals, development of a relevant model to study R. equi infection has proven difficult. The objective of this study was to identify a challenge dose of R. equi that resulted in slow progressive disease, spontaneous regression of lung lesions and age-dependent susceptibility. Foals less than one-week of age were challenged intratracheally using either 10(6), 10(5), 10(4), 10(3) or 10(2) cfu of R. equi. Two doses (10(3) cfu and 10(5) cfu) were used to challenge 2 and 3-week-old, and 3 and 6-week-old foals, respectively. Physical examination, thoracic ultrasound and blood work were performed. Foals were euthanized at the end of the study or when clinical signs of pneumonia developed. All foals were necropsied and their lung lesions scored. Foals challenged with low concentrations of R. equi developed slow progressive pneumonia and approximately 50% of the foals recovered spontaneously. Likewise, macroscopic (>1cm diameter) pyogranulomatous lesions were only observed when low doses of R. equi were used. Clinical pneumonia was not seen after low dose challenge in the 3-week-old foals or in the 6-week-old foals. This study demonstrates that the use of low doses of R. equi to challenge neonatal foals provides an improved model for studying this disease. Furthermore, susceptibility to R. equi infection was shown to diminish early in the foal's life, as has been reported in the field.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age susceptibility; Experimental challenge; Foal; Pyogranulomatous pneumonia; R. equi

Mesh:

Substances:

Year:  2013        PMID: 24139178     DOI: 10.1016/j.vetmic.2013.09.018

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  10 in total

1.  Antibody to Poly-N-acetyl glucosamine provides protection against intracellular pathogens: Mechanism of action and validation in horse foals challenged with Rhodococcus equi.

Authors:  Colette Cywes-Bentley; Joana N Rocha; Angela I Bordin; Mariana Vinacur; Safia Rehman; Tanweer S Zaidi; Mark Meyer; Sarah Anthony; McKenzie Lambert; Daniel R Vlock; Steeve Giguère; Noah D Cohen; Gerald B Pier
Journal:  PLoS Pathog       Date:  2018-07-19       Impact factor: 6.823

2.  Strain-to-strain variation of Rhodococcus equi growth and biofilm formation in vitro.

Authors:  Adina R Bujold; Nicholas R Lani; Macarena G Sanz
Journal:  BMC Res Notes       Date:  2019-08-19

3.  Host-directed therapy in foals can enhance functional innate immunity and reduce severity of Rhodococcus equi pneumonia.

Authors:  Angela I Bordin; Noah D Cohen; Steve Giguère; Jocelyne M Bray; Londa J Berghaus; Brenton Scott; Rena Johnson; Magnus Hook
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

4.  The type of anticoagulant used for plasma collection affects in vitro Rhodococcus equi assays.

Authors:  Alejandra A Rivolta; Dana C Pittman; Amanda J Kappes; Robert K Stancil; Clark Kogan; Macarena G Sanz
Journal:  BMC Res Notes       Date:  2022-02-14

5.  Composition and Diversity of the Fecal Microbiome and Inferred Fecal Metagenome Does Not Predict Subsequent Pneumonia Caused by Rhodococcus equi in Foals.

Authors:  Canaan M Whitfield-Cargile; Noah D Cohen; Jan Suchodolski; M Keith Chaffin; Cole M McQueen; Carolyn E Arnold; Scot E Dowd; Glenn P Blodgett
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

6.  Oral Administration of Electron-Beam Inactivated Rhodococcus equi Failed to Protect Foals against Intrabronchial Infection with Live, Virulent R. equi.

Authors:  Joana N Rocha; Noah D Cohen; Angela I Bordin; Courtney N Brake; Steeve Giguère; Michelle C Coleman; Robert C Alaniz; Sara D Lawhon; Waithaka Mwangi; Suresh D Pillai
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

7.  Transcriptome analysis of immune genes in peripheral blood mononuclear cells of young foals and adult horses.

Authors:  Rebecca L Tallmadge; Minghui Wang; Qi Sun; Maria Julia B Felippe
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

8.  Opsonization but not pretreatment of equine macrophages with hyperimmune plasma nonspecifically enhances phagocytosis and intracellular killing of Rhodococcus equi.

Authors:  Aja B Harvey; Angela I Bordin; Joana N Rocha; Jocelyn M Bray; Noah D Cohen
Journal:  J Vet Intern Med       Date:  2020-12-16       Impact factor: 3.175

9.  Association of pneumonia with concentrations of virulent Rhodococcus equi in fecal swabs of foals before and after intrabronchial infection with virulent R. equi.

Authors:  Noah D Cohen; Susanne K Kahn; Angela I Bordin; Giana M Gonzales; Bibiana Petri da Silveira; Jocelyne M Bray; Rebecca M Legere; Sophia C Ramirez-Cortez
Journal:  J Vet Intern Med       Date:  2022-03-24       Impact factor: 3.175

10.  Serum Antibody Activity against Poly-N-Acetyl Glucosamine (PNAG), but Not PNAG Vaccination Status, Is Associated with Protecting Newborn Foals against Intrabronchial Infection with Rhodococcus equi.

Authors:  Noah D Cohen; Susanne K Kahn; Colette Cywes-Bentley; Sophia Ramirez-Cortez; Amanda E Schuckert; Mariana Vinacur; Angela I Bordin; Gerald B Pier
Journal:  Microbiol Spectr       Date:  2021-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.